WHEN IS CANCER PAIN MILD, MODERATE OR SEVERE - GRADING PAIN SEVERITY BY ITS INTERFERENCE WITH FUNCTION

被引:1198
作者
SERLIN, RC [1 ]
MENDOZA, TR [1 ]
NAKAMURA, Y [1 ]
EDWARDS, KR [1 ]
CLEELAND, CS [1 ]
机构
[1] UNIV WISCONSIN, DEPT EDUC PSYCHOL, MADISON, WI 53706 USA
关键词
PAIN SEVERITY; CANCER PAIN; FUNCTIONAL INTERFERENCE;
D O I
10.1016/0304-3959(94)00178-H
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
As a way of delineating different levels of cancer pain severity, we explored the relationship between numerical ratings of pain severity and ratings of pain's interference with such functions as activity, mood, and sleep. Interference measures were used as critical variables to grade pain severity. We explored the possibility that pain severity could be classified into groupings roughly comparable to mild, moderate, and severe. Our hypothesis was that mild, moderate, and severe pain would differentially impair cancer patients' function. We were able to identify boundaries among these categories of pain severity in terms of their interference with function. We also examined the extent to which cancer patients from different language and cultural groups differ in their self-reported interference as a function of pain severity level. We found optimal cutpoints that form 3 distinct levels of pain severity that can be defined on a 0-10-point numerical scale. We determined that, based on the degree of interference with cancer patients' function, ratings of 1-4 correspond to mild pain, 5-6 to moderate pain, and 7-10 to severe pain. Our analysis illustrates that the pain severity-interference relationship is non-linear. These cutpoints were the same for each of the national samples in our analysis, although there were slight differences in the specific interference items affected by pain. These cutpoints might be useful in clinical evaluation, epidemiology, and clinical trials.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 32 条
  • [1] Beecher, Measurement of Subjective Responses, (1959)
  • [2] Clark, Yang, Applications of sensory decision theory to problems in laboratory and clinical pain, Pain Measurement and Assessment, pp. 15-25, (1983)
  • [3] Cleeland, The impact of pain on the patient with cancer, Cancer, 54, pp. 2635-2641, (1984)
  • [4] Cleeland, Measurement of pain by subjective report, Adbances in Pain Research and Therapy, Vol. 12, Issues in Pain Measurement, pp. 391-403, (1989)
  • [5] Cleeland, Assessment of pain in cancer: measurement issues, Adbances in Pain Research and Therapy, 16, pp. 47-55, (1990)
  • [6] Cleeland, Pain assessment in cancer, Effect of Cancer on Quality of Life, pp. 293-305, (1991)
  • [7] Cleeland, Syrjala, How to assess cancer pain, Pain Assessment, pp. 360-387, (1992)
  • [8] Cleeland, Ladinsky, Serlin, Nugyen, Multidimensional measurement of cancer pain: comparisons of US and Vietnamese patients, J. Pain Sympt. Manag., 3, pp. 23-27, (1988)
  • [9] Cleeland, Gonin, Hatfield, Edmonson, Blum, Stewart, Pandya, Pain and its treatment in outpatients with metastatic cancer, New Engl. J. Med., 330, pp. 592-596, (1994)
  • [10] Daut, Cleeland, The prevalence and severity of pain in cancer, Cancer, 50, pp. 1913-1918, (1982)